Screener
Amylyx Pharmaceuticals, Inc. AMLX Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $5.26M.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s total debt?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported total debt of $5.26M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s total debt changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s total debt decreased by 11.9% year-over-year, from $5.96M to $5.26M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total debt?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s total debt has grown at a -1.7% compound annual growth rate (CAGR), from $6.28M to $5.96M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude